Anew Medical Inc. - WENA Operating profit before deduction of amortization
Anew Medical, Inc. (WENA) is developing gene therapies to combat ALS and Alzheimer's disease. The market's immense potential is driven by a shortage of effective medications. Trial logistics have been optimized through a laboratory network to protect margins. On GURU.Markets, the EBITDA level demonstrates the model's viability, with the metric value standing at .
Anew Medical, Inc. (WENA) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- shareholders' equity book value data:
- company total debt and liquidity indicators:
- earnings and market ratios statistics:
WENA - Company Net Income|Expected Profit Anew Medical, Inc.|WENA - Price to Earnings Ratio|Future Price to Earnings Multiple Anew Medical Inc.|WENA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Anew Medical|WENA - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Anew Medical|WENA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months anewmeds.com|WENA - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Anew Medical, Inc.
Summary company analytics:WENA Anew Medical Inc.
Effective delegation of gene therapy development to external contractors allows Anew Medical, Inc. (WENA) to optimize costs while maintaining full control over intellectual property. The EBITDA_Co trend on this chart reflects the actual cash flow from core operations before taxes and depreciation, enabling investors to assess the business's fundamental solvency and the asset's resilience regardless of accounting adjustments.
Who Anew Medical, Inc. competes with
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|NBIX: Operating profit before deduction of amortization|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before deduction of amortization Viking Therapeutics Corp (VKTX)|Operating profit EBITDA SUPN|CPRX - Profit before interest, taxes and amortization|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|HRMY: Operating profit before amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Operating income before deduction of amortization Amylyx Corp AMLX|TRVI: Operating profit EBITDA|Operating profit before deduction of amortization praxismedicines.com|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Profit before payment of interest, taxes and amortization ALEC (alector.com)|Annexon, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization OMER|Neurogene - Operating profit EBITDA|Operating income before deduction of amortization AC Immune S.A. ACIU|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Operating profit before amortization NMRA|SCLX (Scilex Holding Company) - Operating profit EBITDA|Operating profit before deduction of amortization tevogen.com (TVGN)|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating income before deduction of amortization Cognition Therapeutics Inc.|Inhibikase - Operating profit before deduction of amortization|SAVA - Operating profit before deduction of amortization|Assertio Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization Coya Therapeutics, Inc.|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization OVID|ABOS (Acumen Pharma) - Operating profit EBITDA|Operating profit EBITDA CervoMed Corporation|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|clene.com - Operating profit before amortization|Operating profit EBITDA PEPG (PepGen)|Jupiter Neurosciences, Inc. (JUNS) - Profit before interest, taxes and amortization|RLMD: Operating profit before deduction of amortization|ANVS - Operating profit EBITDA|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|fireflyneuro.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANEW Medical|Profit before interest, taxes and amortization NeuroSense Therapeutics, Ltd. NRSN|Operating profit EBITDA RVPH|Operating profit EBITDA metaviatx.com (MTVA)|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|HSDT: Operating profit before amortization|Passage Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences Corp) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Athira Pharma Corp|Operating profit before deduction of amortization ADXN|ALZN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|Operating profit before deduction of amortization protagenic.com PTIX|Operating profit EBITDA KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Profit before interest, taxes and amortization|Avenue Therapeutics - Operating profit EBITDA|BCLI (brainstorm-cell.com) - Operating profit before amortization|CARA: Operating profit EBITDA|CHRO - Operating income before deduction of amortization|ELYM (Eliem Therapeutics, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Intra-Cellular (ITCI)|Operating profit EBITDA LBPH|Operating profit EBITDA marinuspharma.com (MRNS)|Profit before payment of interest, taxes and amortization NKGen Biotech NKGN|NeuroBo Pharmaceuticals Inc - Profit before payment of interest, taxes and amortization|SAGE: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SNPX (Synaptogenix, Inc)|TRVN: Operating profit EBITDA|VIGL - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
